Skip to content

Program examines hepatitis C, the "silent epidemic"

An estimated 160 million people worldwide are affected by hepatitis C, a virus that attacks the liver and can lead to liver cancer, cirrhosis, and liver failure. It can be decades before symptoms arise, so an estimated 75 percent of patients have no idea they're infected with the virus.

This so-called silent epidemic is the focus of KQED's QUEST. The show discusses the latest research, including a recent discovery of a novel class of compounds that, in experiments in vitro, inhibit replication of the virus. Jeffrey Glenn, MD, PhD, directs Stanford's Center for Hepatitis and Liver Tissue Engineering and led that work. He's featured at the six-minute mark of the video above.

Popular posts

Sex biology redefined: Genes don’t indicate binary sexes

The scenario many of us learned in school is that two X chromosomes make someone female, and an X and a Y chromosome make someone male. These are simplistic ways of thinking about what is scientifically very complex.
Intermittent fasting: Fad or science-based diet?

Are the health-benefit claims from intermittent fasting backed up by scientific evidence? John Trepanowski, postdoctoral research fellow at the Stanford Prevention Research Center,weighs in.